Wayne-based Safeguard Scientific made an announcement March 11 that affects some of its investors.

Those who own its outstanding 2.625 percent Convertible Senior Debentures Due 2024 (CUSIP Number 786449 AG3) have the right to require the company to repurchase these notes for cash.

The repurchase date of the notes is April 8, an extension of the original indenture date. The repurchase price will be 100 percent of the principal amount of the outstanding notes, plus accrued and unpaid interest.

Safeguard, founded in 1953, invests in companies focusing on medical technology, healthcare technology and specialty pharmaceuticals, as well as technology companies focusing on financial technology, internet and digital media, and Enterprise 3.0.

A company repurchase notice is being mailed to all registered note holders. Notes to be repurchased must be surrendered to U.S. Bank National Association as specified in the company repurchase notice. Notes properly tendered for repurchase and not withdrawn prior to the close of business on the repurchase date will receive payment of the repurchase price, plus accrued and unpaid interest up to the repurchase date.

As required by the United States Securities and Exchange Commission, the company will file a Tender Offer Statement on Schedule TO with the SEC. The company repurchase notice and other relevant documents will be filed with the SEC and are available on the SEC’s website here. Documents filed with the SEC may also be obtained without charge at the company’s website here.

Questions about the repurchase notice should be directed to U.S. Bank National Association, Corporate Trust Services, P.O. Box 64111, St. Paul, Mn., 55164-0111, or by calling 800-934-6802.